Mindaugas Galvosas, MD
banner
mgalvosas.bsky.social
Mindaugas Galvosas, MD
@mgalvosas.bsky.social
Cough as a Digital Biomarker and First Digital Therapeutic (DTx) for chronic cough @ hyfe.com, coughpro.com | prev. founder of wandering prevention tech for dementia | interested in Digital Health | my opinions
The value of continuous cough monitoring: a narrative review - done with Peter Small - is #OpenAccess at Journal Of Thoracic Diseases

jtd.amegroups.org/article/view...
The value of continuous cough monitoring: a narrative review
The value of continuous cough monitoring: a narrative review
jtd.amegroups.org
December 1, 2025 at 11:44 AM
-> a digital biofeedback system for novel digital therapeutics (DTx) for cough hypersensitivity as a treatable trait of other conditions

journal.chestnet.org/article/S001...
DIGITAL THERAPEUTIC FOR REFRACTORY AND UNEXPLAINED CHRONIC COUGH: A PROOF OF CONCEPT STUDY
SESSION TITLE: Late-Breaking Scientific Abstracts Posters: Airways, Obstructive Lung Diseases, Bronch&CF
journal.chestnet.org
December 1, 2025 at 11:44 AM
...
-> a digital predictive biomarker of exacerbations (asthma, COPD) or decompensation/congestion (CHF)

-> a digital treatment response biomarker, supporting personalised management strategies (eg airway clearance in bronchiectasis)
...
December 1, 2025 at 11:44 AM
2. The value of continuous cough monitoring insights across a range of therapeutic areas (refractory chronic cough, COPD, bronchiectasis, congestive heart failure, GERD, TB, malaria) and use cases:

-> a method to account for natural cough variability

-> an endpoint in drug development
...
December 1, 2025 at 11:44 AM
1. The landscape of modern cough monitoring tools - by Albus Health, C-mo Medical Solutions, Hyfe, SIVA Health, Strados Labs
December 1, 2025 at 11:44 AM
‪Super interesting! I wonder what will objective cough data (eg as available on smartwatch wearables) show in this group! ‬
November 26, 2025 at 9:53 PM